Neovasc

$0.952
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.058 (-5.74%) As of 7:01 PM UTC today

Why Robinhood?

You can buy or sell Neovasc and other stocks, options, and ETFs commission-free!

About NVCN

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products.

CEO
Fredericus Antonius Colen
Employees
71
Headquarters
Richmond, British Columbia
Founded
2000
Market Cap
65.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.25M
High Today
$1.02
Low Today
$0.9518
Open Price
$1.00
Volume
2.01M
52 Week High
$3.88
52 Week Low
$0.68

NVCN Earnings

-$1.45
-$0.97
-$0.48
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 6, After Hours

You May Also Like

INVE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure